OraSure Technologies Inc. (NASDAQ:OSUR) was up 9.6% during mid-day trading on Monday . The company traded as high as $8.60 and last traded at $8.60, with a volume of 2,308,350 shares traded. The stock had previously closed at $7.85.

A number of equities research analysts recently issued reports on OSUR shares. Mizuho reiterated a “buy” rating and issued a $8.00 price objective on shares of OraSure Technologies in a research report on Friday, May 6th. Zacks Investment Research upgraded OraSure Technologies from a “hold” rating to a “buy” rating and set a $7.50 price objective on the stock in a research report on Saturday, May 7th. Raymond James Financial Inc. downgraded OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 price objective on the stock. in a research report on Monday, June 13th. BTIG Research reiterated a “buy” rating and issued a $9.00 price objective on shares of OraSure Technologies in a research report on Wednesday, June 29th. Finally, TheStreet downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 1st. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. OraSure Technologies presently has an average rating of “Buy” and a consensus price target of $8.58.

The firm’s 50 day moving average price is $6.97 and its 200-day moving average price is $6.96. The stock has a market cap of $477.05 million and a price-to-earnings ratio of 40.86.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02. The business had revenue of $31.36 million for the quarter, compared to the consensus estimate of $31.15 million. The company’s revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.03 EPS. Analysts forecast that OraSure Technologies Inc. will post $0.27 EPS for the current fiscal year.

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.